Journal
DEVELOPMENTAL CELL
Volume 22, Issue 4, Pages 887-901Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2012.01.005
Keywords
-
Categories
Funding
- Heart and Stroke Foundation of Ontario [NA-6636]
- Canadian Institutes of Health Research (CIHR) [MOP77803, MOP106538]
- Wellcome Trust [WT093736]
- Swedish Research Council
- Ontario Graduate Studentship in Science and Technology
- Canada Research Chair Program
- Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H331] Funding Source: researchfish
- BBSRC [BBS/E/B/0000H331] Funding Source: UKRI
Ask authors/readers for more resources
The advent of reprogramming and its impact on stem cell biology has renewed interest in lineage restriction in mammalian embryos, the source of embryonic (ES), epiblast (EpiSC), trophoblast (TS), and extraembryonic endoderm (XEN) stem cell lineages. Isolation of specific cell types during stem cell differentiation and reprogramming, and also directly from embryos, is a major technical challenge because few cell-surface proteins are known that can distinguish each cell type. We provide a large-scale proteomic resource of cell-surface proteins for the four embryo-derived stem cell lines. We validated 27 antibodies against lineage-specific cell-surface markers, which enabled investigation of specific cell populations during ES-EpiSC reprogramming and ES-to-XEN differentiation. Identified markers also allowed prospective isolation and characterization of viable lineage progenitors from blastocysts by flow cytometry. These results provide a comprehensive stem cell proteomic resource and enable new approaches to interrogate the mechanisms that regulate cell fate specification.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available